Saniona aspires to become a leading rare disease biopharmaceutical company focused on treatments for central nervous system disorders. Saniona’s overall objective is to identify, develop and ultimately commercialize its proprietary products focused on rare diseases where there is a significant unmet medical needs. Saniona also intends to continue to collaborate and out-license molecules intended for broader indications to other larger pharmaceutical companies.